Guilin Sanjin Pharmaceutical Co., Ltd. (SHE:002275)

China · Delayed Price · Currency is CNY

14.20

-0.21 (-1.46%)

Apr 9, 2026, 11:49 AM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Industry	2.12B	2.10B	1.87B	-	-
Industry Growth	1.10%	12.27%	-	-	-
Commodity Circulation (Commercial)	41.25M	46.19M	48.85M	43.87M	43.98M
Commodity Circulation (Commercial) Growth	-10.69%	-5.45%	11.35%	-0.25%	-
Other Business	31.75M	27.41M	42.15M	18.38M	7.93M
Other Business Growth	15.84%	-34.98%	129.37%	131.74%	-
Chinese Patent Medicine (Industry)	-	-	-	1.59B	1.43B
Chinese Patent Medicine (Industry) Growth	-	-	-	11.49%	-
Other (Industrial)	-	-	-	88.19M	87.72M
Other (Industrial) Growth	-	-	-	0.54%	-
Total	2.19B	2.17B	1.96B	1.74B	1.57B
Total Growth	1.03%	10.81%	12.55%	11.15%	-

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
China	2.18B	2.16B	1.95B	1.73B	1.55B
China Growth	1.06%	10.81%	12.52%	11.80%	-
Overseas	11.84M	12.35M	11.12M	9.45M	17.51M
Overseas Growth	-4.14%	10.98%	17.72%	-46.04%	-
Total	2.19B	2.17B	1.96B	1.74B	1.57B
Total Growth	1.03%	10.81%	12.55%	11.15%	-

Source: S&P Global Market Intelligence.